[Immunosuppressive therapy of progredient chronic polyarthritis].
D000284:Administration, Oral; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D003967:Diarrhea / Q000139:chemically induced; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000150:complications; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011033:Podophyllin / Q000009:adverse effects / Q000627:therapeutic use; D011704:Pyelonephritis / Q000150:complications
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D011033:Podophyllin
Immunsuppressive Therapie der progredient chronischen Polyarthritis